Qiagen (QGEN) Liabilities and Shareholders Equity (2009 - 2026)
Qiagen (QGEN) posted Liabilities and Shareholders Equity of $5.8 billion for Q1 2026, down 7.95% sequentially from $6.3 billion in Q4 2025, and up 4.27% YoY from $5.5 billion in Q1 2025.
Qiagen (QGEN) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
Qiagen has reported Liabilities and Shareholders Equity for 18 years, with the latest figure at $5.8 billion in Q1 2026.
- Quarterly Liabilities and Shareholders Equity rose 4.27% year-over-year to $5.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.4 billion (up 5.85% YoY) and the FY2025 annual result came in at $6.3 billion, up 10.4% from the prior year.
- Liabilities and Shareholders Equity fell to $5.8 billion in Q1 2026 per QGEN's latest filing, from $6.3 billion in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $6.6 billion in Q3 2025 and troughed at $5.5 billion in Q1 2025.
- A 5-year average of $6.1 billion and a median of $6.2 billion in 2022 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity slipped 12.02% in 2024, then increased 10.4% in 2025.
- Over 5 years, Liabilities and Shareholders Equity stood at $6.3 billion in 2022, then retreated by 2.74% to $6.1 billion in 2023, then slipped by 6.96% to $5.7 billion in 2024, then rose by 10.4% to $6.3 billion in 2025, then decreased by 7.95% to $5.8 billion in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $5.8 billion, $6.3 billion, and $6.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 113.17 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 92.37 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 3.44 Bn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 13.07 Bn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 29.88 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 2.61 Bn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 6.65 Bn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 3.67 Bn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 16.94 Bn |
| 10 | Qiagen | 8.65 Bn | 8.65 Bn | - | 5.78 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.78 Bn |
| Dec 31, 2025 | 6.28 Bn |
| Sep 30, 2025 | 6.55 Bn |
| Jun 30, 2025 | 5.82 Bn |
| Mar 31, 2025 | 5.55 Bn |
| Dec 31, 2024 | 5.69 Bn |
| Sep 30, 2024 | 6.27 Bn |
| Jun 30, 2024 | 5.58 Bn |
| Mar 31, 2024 | 5.81 Bn |
| Dec 31, 2023 | 6.12 Bn |
| Sep 30, 2023 | 5.91 Bn |
| Jun 30, 2023 | 6.35 Bn |
| Mar 31, 2023 | 6.28 Bn |
| Dec 31, 2022 | 6.29 Bn |
| Sep 30, 2022 | 6.52 Bn |
| Jun 30, 2022 | 6.15 Bn |
| Mar 31, 2022 | 6.18 Bn |
| Dec 31, 2021 | 6.15 Bn |
| Sep 30, 2021 | 6.04 Bn |
| Jun 30, 2021 | 5.91 Bn |